Italy has blocked the export of some doses of AstraZeneca vaccine to Australia (“not vulnerable country”) on the basis of Commission Implementing Regulation (EU) 2021/111

Commission Implementing Regulation (EU) 2021/111 of 29 January 2021 making the exportation of certain products subject to the production of an export authorisation

CELEX32021R0111ENTXT

“Despite the fact that financial support has been given to increase production, certain vaccine manufacturers have already announced that they would not be in a position to supply the quantities of vaccine destined to the Union that they had pledged, in potential breach of their contractual commitments. Furthermore, there is a risk that vaccines produced in the Union are exported from the Union, in particular to non-vulnerable countries. Such a potential breach of contractual commitments made by the pharmaceutical industries, carries the risk of shortages and therefore delays within the Union. Such delays severely disrupt the Union’s plan to inoculate its population.”

Questa voce è stata pubblicata in Corona Virus. Contrassegna il permalink.

Lascia un commento